Skip to content
10-Q

Quarterly Report

ALBANY MOLECULAR RESEARCH INC

0001144204-17-025756

← back to feed
Filed
May 10, 2017 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2017 · Apr 30, 2017 42.93M sh
Stock Repurchased Q1 2017 · Mar 31, 2017 $1.88M
Stock Repurchased Q1 2017 · Mar 31, 2016 $714K
Capex Q1 2017 · Mar 31, 2017 $3.95M
Capex Q1 2017 · Mar 31, 2016 $11.63M
Long Term Debt Q1 2017 · Mar 31, 2017 $607.25M
Long Term Debt Q1 2017 · Dec 31, 2016 $604.48M
Short Term Debt Q1 2017 · Mar 31, 2017 $20.84M
Short Term Debt Q1 2017 · Dec 31, 2016 $22.52M
Cash And Equivalents Q1 2017 · Mar 31, 2017 $35.19M
Cash And Equivalents Q1 2017 · Dec 31, 2016 $52M
Stockholders Equity Q1 2017 · Mar 31, 2017 $296.8M
Stockholders Equity Q1 2017 · Dec 31, 2016 $298.98M
Current Liabilities Q1 2017 · Mar 31, 2017 $167.01M
Current Liabilities Q1 2017 · Dec 31, 2016 $175.52M
Total Liabilities Q1 2017 · Mar 31, 2017 $866.73M
Total Liabilities Q1 2017 · Dec 31, 2016 $910.67M
Current Assets Q1 2017 · Mar 31, 2017 $385.15M
Current Assets Q1 2017 · Dec 31, 2016 $392.91M
Total Assets Q1 2017 · Mar 31, 2017 $1.16B
Total Assets Q1 2017 · Dec 31, 2016 $1.21B
Sga Expense Q1 2017 · Mar 31, 2017 $33.43M
Sga Expense Q1 2017 · Mar 31, 2016 $24.6M
Rd Expense Q1 2017 · Mar 31, 2017 $3.37M
Rd Expense Q1 2017 · Mar 31, 2016 $3.17M
Net Income Q1 2017 · Mar 31, 2017 −$10.69M
Net Income Q1 2017 · Mar 31, 2016 −$10.07M
Operating Income Q1 2017 · Mar 31, 2017 $2.08M
Operating Income Q1 2017 · Mar 31, 2016 −$4.15M
Revenue Q1 2017 · Mar 31, 2017 $163.82M
Revenue Q1 2017 · Mar 31, 2016 $105.58M